Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Babyl & Novo Nordisk Partner to Provide an Innovative Approach to Diabetes Awareness and Care in Rwanda
Babyl, a subsidiary of Babylon, and Novo Nordisk announced today that they have entered an […]
BRIM Biotechnology Raises $20 Million in Series E Funding Round
BRIM Biotechnology, a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure […]
Monica Chopra Joins Auxa Health as Co-Founder & CEO
Auxa Health, a leading social care orchestration technology company, announced Monica Chopra, MBA, MPH as its […]
UpStream and Tidewater Physicians Multispecialty Group Announce Partnership
UpStream, a value-based management services organization based in Greensboro, NC with a unique model of […]
Acer Therapeutics Announces $1.5M Private Placement
Acer Therapeutics, a pharmaceutical company focused on the acquisition, development and commercialization of therapies for […]
BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
IPA (Immunoprecise Antibodies), an advanced biotherapeutic research and technology company, today announced that BioStrand BV, […]
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Pulmonx Corporation, a global leader in minimally invasive treatments for severe lung disease, announced today […]
Novo Integrated Sciences’ Subsidiary, Clinical Consultants International, Signs Consulting Agreement with Pharmaceutical Research & Development Company
Novo Integrated Sciences and Clinical Consultants International (CCI), a Novo wholly-owned subsidiary, has announced the […]
Aurion Biotech Expands Its Leadership Team
Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing […]
Metrion Biosciences Invests in New High Throughput Screening Capability and Expanded Facilities
Metrion Biosciences, the specialist ion channel contract research and drug discovery company, has announced the […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more